SE543316C2 - Yeast for the treatment of allergy - Google Patents
Yeast for the treatment of allergyInfo
- Publication number
- SE543316C2 SE543316C2 SE1951142A SE1951142A SE543316C2 SE 543316 C2 SE543316 C2 SE 543316C2 SE 1951142 A SE1951142 A SE 1951142A SE 1951142 A SE1951142 A SE 1951142A SE 543316 C2 SE543316 C2 SE 543316C2
- Authority
- SE
- Sweden
- Prior art keywords
- ghz
- allergy
- cfus
- yeast cell
- minutes
- Prior art date
Links
- 206010020751 Hypersensitivity Diseases 0.000 title claims abstract description 93
- 208000026935 allergic disease Diseases 0.000 title claims abstract description 91
- 230000007815 allergy Effects 0.000 title claims abstract description 91
- 238000011282 treatment Methods 0.000 title claims abstract description 49
- 240000004808 Saccharomyces cerevisiae Species 0.000 title description 53
- 210000005253 yeast cell Anatomy 0.000 claims abstract description 56
- 208000024891 symptom Diseases 0.000 claims abstract description 47
- 239000000203 mixture Substances 0.000 claims abstract description 43
- 210000004027 cell Anatomy 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 13
- 206010039085 Rhinitis allergic Diseases 0.000 claims description 12
- 201000010105 allergic rhinitis Diseases 0.000 claims description 12
- 208000006673 asthma Diseases 0.000 claims description 12
- 241001465754 Metazoa Species 0.000 claims description 10
- 239000013566 allergen Substances 0.000 claims description 9
- 208000004262 Food Hypersensitivity Diseases 0.000 claims description 8
- 206010016946 Food allergy Diseases 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 6
- 235000020932 food allergy Nutrition 0.000 claims description 5
- 241000235070 Saccharomyces Species 0.000 claims description 4
- 206010039083 rhinitis Diseases 0.000 claims description 4
- 206010048908 Seasonal allergy Diseases 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 206010003645 Atopy Diseases 0.000 claims description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 52
- 239000003814 drug Substances 0.000 description 44
- 229940079593 drug Drugs 0.000 description 33
- 230000006872 improvement Effects 0.000 description 30
- 239000002775 capsule Substances 0.000 description 26
- 241000282326 Felis catus Species 0.000 description 19
- 235000021152 breakfast Nutrition 0.000 description 18
- 230000005722 itchiness Effects 0.000 description 18
- 241000282472 Canis lupus familiaris Species 0.000 description 17
- 210000001508 eye Anatomy 0.000 description 17
- 230000010355 oscillation Effects 0.000 description 16
- 206010041232 sneezing Diseases 0.000 description 16
- 230000001932 seasonal effect Effects 0.000 description 15
- 241000283073 Equus caballus Species 0.000 description 14
- 206010042674 Swelling Diseases 0.000 description 13
- 230000008961 swelling Effects 0.000 description 13
- 244000025254 Cannabis sativa Species 0.000 description 10
- 208000003251 Pruritus Diseases 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- 241000124008 Mammalia Species 0.000 description 8
- 208000010668 atopic eczema Diseases 0.000 description 8
- 239000000428 dust Substances 0.000 description 8
- 241000283690 Bos taurus Species 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 208000024780 Urticaria Diseases 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 206010013952 Dysphonia Diseases 0.000 description 5
- 208000010473 Hoarseness Diseases 0.000 description 5
- 206010043528 Throat tightness Diseases 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 229960003088 loratadine Drugs 0.000 description 5
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000005855 radiation Effects 0.000 description 5
- 241000238876 Acari Species 0.000 description 4
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- 206010015967 Eye swelling Diseases 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 230000000172 allergic effect Effects 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 230000032823 cell division Effects 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 238000002483 medication Methods 0.000 description 4
- 239000007922 nasal spray Substances 0.000 description 4
- 210000003800 pharynx Anatomy 0.000 description 4
- 230000029058 respiratory gaseous exchange Effects 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 206010012434 Dermatitis allergic Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 235000011430 Malus pumila Nutrition 0.000 description 3
- 235000015103 Malus silvestris Nutrition 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000037656 Respiratory Sounds Diseases 0.000 description 3
- 208000036071 Rhinorrhea Diseases 0.000 description 3
- 206010039101 Rhinorrhoea Diseases 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 206010047924 Wheezing Diseases 0.000 description 3
- 229960004784 allergens Drugs 0.000 description 3
- 235000013681 dietary sucrose Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 210000003097 mucus Anatomy 0.000 description 3
- 208000013220 shortness of breath Diseases 0.000 description 3
- 229960004793 sucrose Drugs 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 235000009434 Actinidia chinensis Nutrition 0.000 description 2
- 244000298697 Actinidia deliciosa Species 0.000 description 2
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- 206010002199 Anaphylactic shock Diseases 0.000 description 2
- 206010008469 Chest discomfort Diseases 0.000 description 2
- 206010010744 Conjunctivitis allergic Diseases 0.000 description 2
- 240000009226 Corylus americana Species 0.000 description 2
- 235000001543 Corylus americana Nutrition 0.000 description 2
- 235000007466 Corylus avellana Nutrition 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102100026011 Interleukin-13 Human genes 0.000 description 2
- 241000220225 Malus Species 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 208000002205 allergic conjunctivitis Diseases 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 229940125715 antihistaminic agent Drugs 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 208000024998 atopic conjunctivitis Diseases 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 235000021577 malt beverage Nutrition 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 229940097496 nasal spray Drugs 0.000 description 2
- 235000014571 nuts Nutrition 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 229940081969 saccharomyces cerevisiae Drugs 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000003867 tiredness Effects 0.000 description 2
- 208000016255 tiredness Diseases 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 1
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002653 Anosmia Diseases 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010052140 Eye pruritus Diseases 0.000 description 1
- 108010028690 Fish Proteins Proteins 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 206010052437 Nasal discomfort Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 108010003571 Nut Proteins Proteins 0.000 description 1
- JWOLLWQJKQOEOL-UHFFFAOYSA-N OOOOOOOOOOOOO Chemical compound OOOOOOOOOOOOO JWOLLWQJKQOEOL-UHFFFAOYSA-N 0.000 description 1
- 206010037884 Rash pruritic Diseases 0.000 description 1
- 206010039094 Rhinitis perennial Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 206010070488 Upper-airway cough syndrome Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000013567 aeroallergen Substances 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 1
- 229960002537 betamethasone Drugs 0.000 description 1
- 208000030303 breathing problems Diseases 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000013568 food allergen Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940046528 grass pollen Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 229960000381 omeprazole Drugs 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 208000022719 perennial allergic rhinitis Diseases 0.000 description 1
- 201000004338 pollen allergy Diseases 0.000 description 1
- URKOMYMAXPYINW-UHFFFAOYSA-N quetiapine Chemical compound C1CN(CCOCCO)CCN1C1=NC2=CC=CC=C2SC2=CC=CC=C12 URKOMYMAXPYINW-UHFFFAOYSA-N 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000008786 sensory perception of smell Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229960000195 terbutaline Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0023—Agression treatment or altering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/02—Radiation therapy using microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/85—Saccharomyces
- C12R2001/86—Saccharomyces carlsbergensis ; Saccharomyces pastorianus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/85—Saccharomyces
- C12R2001/865—Saccharomyces cerevisiae
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1951142A SE543316C2 (en) | 2019-10-07 | 2019-10-07 | Yeast for the treatment of allergy |
| PCT/SE2020/050958 WO2021071413A1 (en) | 2019-10-07 | 2020-10-07 | Yeast for the treatment of allergy |
| KR1020227012012A KR20220078603A (ko) | 2019-10-07 | 2020-10-07 | 알레르기의 치료를 위한 효모 |
| IL291913A IL291913A (en) | 2019-10-07 | 2020-10-07 | Yeast for allergy treatment |
| US17/766,959 US20240066083A1 (en) | 2019-10-07 | 2020-10-07 | Yeast for the treatment of allergy |
| CA3151451A CA3151451A1 (en) | 2019-10-07 | 2020-10-07 | Yeast for the treatment of allergy |
| JP2022520001A JP2022550551A (ja) | 2019-10-07 | 2020-10-07 | アレルギー治療のための酵母 |
| CN202080069108.XA CN114514029B (zh) | 2019-10-07 | 2020-10-07 | 用于治疗过敏的酵母 |
| EP20873467.3A EP4041267A4 (en) | 2019-10-07 | 2020-10-07 | YEAST FOR ALLERGY TREATMENT |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1951142A SE543316C2 (en) | 2019-10-07 | 2019-10-07 | Yeast for the treatment of allergy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE1951142A1 SE1951142A1 (en) | 2020-11-24 |
| SE543316C2 true SE543316C2 (en) | 2020-11-24 |
Family
ID=73457659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE1951142A SE543316C2 (en) | 2019-10-07 | 2019-10-07 | Yeast for the treatment of allergy |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240066083A1 (zh) |
| EP (1) | EP4041267A4 (zh) |
| JP (1) | JP2022550551A (zh) |
| KR (1) | KR20220078603A (zh) |
| CN (1) | CN114514029B (zh) |
| CA (1) | CA3151451A1 (zh) |
| IL (1) | IL291913A (zh) |
| SE (1) | SE543316C2 (zh) |
| WO (1) | WO2021071413A1 (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4362963A1 (en) * | 2021-06-29 | 2024-05-08 | Milmed Unico AB | Yeast for the treatment of inflammation |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6793933B2 (en) * | 2002-06-28 | 2004-09-21 | Ultra Biotech Limited | Dietary supplements for enhancing the immune system |
| US7256026B2 (en) * | 2002-06-28 | 2007-08-14 | Ultra Biotech Limited | Oral compositions for white blood cell activation and proliferation |
| WO2004108919A1 (en) * | 2003-06-11 | 2004-12-16 | Ultra Biotech Limited | Biological compositions comprising yeast cells and methods for treatment of cancer |
| JP4712289B2 (ja) * | 2003-08-26 | 2011-06-29 | 株式会社エイ・エル・エイ | 免疫促進用組成物 |
| JP4221266B2 (ja) * | 2003-10-02 | 2009-02-12 | 有限会社カンズ研究開発 | アレルギー性疾患の症状を抑制・緩和するための薬剤 |
| JP4273157B2 (ja) * | 2007-01-26 | 2009-06-03 | オハヨー乳業株式会社 | 抗アレルギー効果のあるケフィア様炭酸含有ヨーグルトおよびその製造方法 |
| JP2010209015A (ja) * | 2009-03-11 | 2010-09-24 | Ohayo Dairy Product | 抗アレルギー用組成物及びそれを含有する抗アレルギー剤および抗アレルギー食品 |
| PL2470213T3 (pl) * | 2009-08-26 | 2014-05-30 | Milmed Ab | Kompozycje do leczenia chorób lub zaburzeń neurodegeneracyjnych, sposób i zastosowanie obejmujące elektromagnetycznie napromienione drożdże |
| JP6002452B2 (ja) * | 2012-06-04 | 2016-10-05 | 木曽町 | 新規酵母及びこれを含む医薬又は飲食品 |
| KR101898508B1 (ko) * | 2017-05-02 | 2018-09-19 | 한림대학교 산학협력단 | 효모 전기 자극 추출물을 포함하는 천식 개선용 식품 조성물 또는 천식 치료 또는 예방용 약학 조성물 |
-
2019
- 2019-10-07 SE SE1951142A patent/SE543316C2/en unknown
-
2020
- 2020-10-07 WO PCT/SE2020/050958 patent/WO2021071413A1/en active Application Filing
- 2020-10-07 US US17/766,959 patent/US20240066083A1/en active Pending
- 2020-10-07 KR KR1020227012012A patent/KR20220078603A/ko unknown
- 2020-10-07 CN CN202080069108.XA patent/CN114514029B/zh active Active
- 2020-10-07 JP JP2022520001A patent/JP2022550551A/ja active Pending
- 2020-10-07 CA CA3151451A patent/CA3151451A1/en active Pending
- 2020-10-07 IL IL291913A patent/IL291913A/en unknown
- 2020-10-07 EP EP20873467.3A patent/EP4041267A4/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220078603A (ko) | 2022-06-10 |
| CA3151451A1 (en) | 2021-04-15 |
| EP4041267A1 (en) | 2022-08-17 |
| US20240066083A1 (en) | 2024-02-29 |
| EP4041267A4 (en) | 2024-01-03 |
| SE1951142A1 (en) | 2020-11-24 |
| IL291913A (en) | 2022-06-01 |
| JP2022550551A (ja) | 2022-12-02 |
| WO2021071413A1 (en) | 2021-04-15 |
| CN114514029B (zh) | 2024-03-08 |
| CN114514029A (zh) | 2022-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019203012A (ja) | 醗酵乳製品およびその使用 | |
| US20080286388A1 (en) | Pharmaceutical Composition and Non Dependence Coffee Comprising Edible Carboxylic Acid and/or Its Acid Salts and Coffeine | |
| JP2006524193A5 (zh) | ||
| US20120100235A1 (en) | Papaya puree and uses thereof | |
| KR20160065497A (ko) | 숙취 해소용 음료의 제조 방법 및 숙취 해소용 음료 | |
| US20240066083A1 (en) | Yeast for the treatment of allergy | |
| JP2011500016A (ja) | 緑茶及び乳酸菌を含む、アトピー治療用乳児用粉乳 | |
| CN107557204B (zh) | 一种混酿荔枝玫瑰酒及其制备方法 | |
| CN107557254B (zh) | 一种荔枝玫瑰酒和制备方法及补益气血与抗氧化应用 | |
| KR101844591B1 (ko) | 진생 베리를 이용한 경옥고 제조방법 및 이에 따라 제조된 경옥고 | |
| JP2818458B2 (ja) | バナバ飲用物の製造方法 | |
| CN113197268A (zh) | 一种醒酒护肝的软饮料及其制备方法 | |
| KR101982129B1 (ko) | 숙취해소음료 및 그 제조방법 | |
| JPH03209330A (ja) | ３α−ヒドロキシステロイドデヒドロゲナーゼ阻害活性剤およびヒアルロニダーゼ阻害活性剤 | |
| EP1398036B1 (en) | Ganoderma lucidum spores for treatment of systemic lupus erytrhomatosus (SLE) | |
| CN107213194A (zh) | 一种治疗糖尿病药物的制备方法 | |
| CN106472672A (zh) | 一种具有增强免疫力功能的香蕉口服液及其制备方法 | |
| KR101331668B1 (ko) | 발효 초약 효소의 제조 방법 | |
| CN110916079A (zh) | 一种可疏风清热的粘豆包及其制作方法 | |
| CN117256848A (zh) | 一种用于祛湿健脾养肺的组合物及其制备方法 | |
| CN116672430A (zh) | 一种抗衰老镇静安神组合物及其应用 | |
| CN109045072A (zh) | 一种用于晚期癌症止痛的食用菌液态菌药 | |
| CN113481132A (zh) | 一种三联氮源速生益生菌液及肉质层培养制备方法及应用 | |
| Calomel | PRACTICAL NOTESandFORMULAS | |
| THOMPSON | INDIGESTION AND ITS MANAGEMENT. |